-
1221“…BACKGROUND: Coverage estimates for pneumococcal vaccination in the United States come from the National Health Interview Survey (NHIS) and do not differentiate between 13-valent conjugated vaccine (PCV13) and 23-valent polysaccharide vaccine (PPSV23). …”
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1222por Meek, Bob, Ekström, Nina, Kantsø, Bjørn, Almond, Rachael, Findlow, Jamie, Gritzfeld, Jenna F., Sværke Jørgensen, Charlotte, Ljungberg, Karl, Atterfelt, Fredrik, Batstra, Manou R., Andeweg, Kevin, de Jong, Ben A. W., Prince, Harry E., Lapé-Nixon, Mary, Gageldonk, Pieter G. M., Tcherniaeva, Irina, Aaberge, Ingeborg, Herstad, Tove Karin, Melin, Merit, Rijkers, Ger T., Berbers, Guy A.“…Surveillance studies are required to estimate the impact of pneumococcal vaccination in both children and the elderly across Europe. …”
Publicado 2019
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1223por Wang, Yuheng, Cheng, Minna, Wang, Siyuan, Wu, Fei, Yan, Qinghua, Yang, Qinping, Li, Yanyun, Guo, Xiang, Fu, Chen, Shi, Yan, Wagner, Abram L., Boulton, Matthew L.“…CONCLUSIONS: We found low levels with of pneumococcal vaccination, and extremely low uptake of influenza vaccination among individuals with high risk conditions in Shanghai who should be priority groups targeted for vaccination. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1224por Kiltz, Uta, Celik, Aylin, Tsiami, Styliani, Buehring, Bjoern, Baraliakos, Xenofon, Andreica, Ioana, Kiefer, David, Braun, Juergen“…Only 49% of patients had undergone pneumococcal vaccination and less than 30% were protected against HepB and influenza, while 7.6% have not protective antibody titres against measles. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1225por Peng, Shihui, Ren, Hongyu, Deng, Jianping, Zhao, Na, Li, Yinan, Li, Ming, Yuan, Qiwu, Zhang, Zhengdong, Luo, Longze, Zeng, Linzi, Wang, Bin, Zou, Nianli, Gu, Changguo, Huang, Xin, Liao, Zheng, Chen, Shenen, Chen, Haiying, Li, Qun, Qin, Tian“…Our findings may supply new guidance for developing new pneumococcal vaccines.…”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1226por Beissbarth, Jemima, Smith-Vaughan, Heidi C., Cheng, Allen C., Morris, Peter S., Leach, Amanda J.“…Outcome measures include clinical examinations (focusing on OM), antibiotic prescriptions, pneumococcal vaccination, modifiable risk factors such as smoking and household crowding, and nasopharyngeal and ear discharge microbiology including antimicrobial resistance testing. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1227por Qian, George, Toizumi, Michiko, Clifford, Sam, Le, Lien Thuy, Papastylianou, Tasos, Satzke, Catherine, Quilty, Billy, Iwasaki, Chihiro, Kitamura, Noriko, Takegata, Mizuki, Bui, Minh Xuan, Nguyen, Hien Anh Thi, Dang, Duc Anh, van Hoek, Albert Jan, Yoshida, Lay Myint, Flasche, Stefan“…Their added protection through herd effects is a key part in the considerations on optimal pneumococcal vaccination strategies. Yet, little is currently known about the main transmission pathways to this vulnerable age group. …”
Publicado 2022
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1228por Palmborg, Andreas, Skovdal, Mette, Molden, Tor, Åhman, Heidi, Chen, Lingjing, Banefelt, Jonas“…During the study period Denmark and Norway used PCV13 in their paediatric NIP, Sweden both PCV10 and PCV13 and Finland used PCV10. Uptake of pneumococcal vaccines for the elderly was low. METHOD: We collected longitudinal data on confirmed IPD cases and their serotypes among elderly people (aged ≥65 years) 2010–2019 in the four countries of interest. …”
Publicado 2023
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1229“…BACKGROUND: At present, available pneumococcal vaccines have failed to eradicate infections caused by S. pneumoniae. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1230por Gritzfeld, Jenna F., Wright, Angie D., Collins, Andrea M., Pennington, Shaun H., Wright, Adam K.A., Kadioglu, Aras, Ferreira, Daniela M., Gordon, Stephen B.“…AIM: We aim to develop an EHPC platform that is a safe and useful reproducible method that could be used to down-select candidate novel pneumococcal vaccines with prevention of carriage as a surrogate of vaccine induced immunity. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1231por Schlaudecker, Elizabeth P., Steinhoff, Mark C., Omer, Saad B., McNeal, Monica M., Roy, Eliza, Arifeen, Shams E., Dodd, Caitlin N., Raqib, Rubhana, Breiman, Robert F., Zaman, K.“…Greater exclusivity of breastfeeding in the first 6 months of life significantly decreased the expected number of respiratory illness with fever episodes in infants of influenza-vaccinated mothers (p = 0.0042) but not in infants of pneumococcal-vaccinated mothers (p = 0.4154). CONCLUSIONS: The sustained high levels of actively produced anti-influenza IgA in breast milk and the decreased infant episodes of respiratory illness with fever suggest that breastfeeding may provide local mucosal protection for the infant for at least 6 months. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1232por Enweronu-Laryea, Christabel C, Boamah, Isaac, Sifah, Eric, Diamenu, Stanley K, Armah, George“…Ghana introduced rotavirus and pneumococcal vaccination in the national expanded program on immunization in May 2012. …”
Publicado 2014
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1233por Gomez, Jorge Alberto, Tirado, Juan Carlos, Navarro Rojas, Aldo Amador, Castrejon Alba, Maria Mercedes, Topachevskyi, Oleksandr“…BACKGROUND: The clinical and economic burden associated with invasive and non-invasive pneumococcal and non-typeable Haemophilus influenzae (NTHi) diseases is substantial in the Latin America and Caribbean region, where pneumococcal vaccines have only been introduced to a few countries. …”
Publicado 2013
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1234por Fischer, Lara, Gerstel, Patricia Francis, Poncet, Antoine, Siegrist, Claire-Anne, Laffitte, Emmanuel, Gabay, Cem, Seebach, Joerg Dieter, Ribi, Camillo“…Little is known about the efficacy of pneumococcal vaccines during immunosuppressive treatment. …”
Publicado 2015
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1235“…CONCLUSIONS: It is important to closely monitor not only evolving serotypes but also the magnitude of the effect in order to evaluate the overall impact of pneumococcal vaccination programmes and to initiate the appropriate vaccination strategy. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1236por Aho, Celestine, Michael, Audrey, Yoannes, Mition, Greenhill, Andrew, Jacoby, Peter, Reeder, John, Pomat, William, Saleu, Gerard, Namuigi, Pioto, Phuanukoonnon, Suparat, Smith-Vaughan, Heidi, Leach, Amanda J., Richmond, Peter, Lehmann, Deborah“…While serotype-independent pneumococcal vaccines are needed in high-risk populations, the underlying environmental factors and sources of infection must be investigated. http://clinicaltrials.gov/ct2/show/NCT00219401.…”
Publicado 2016
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1237por Berger, Yael, Averbuch, Diana, Adler, Amos, Tenenbaum, Ariel, Temper, Violeta, Grisaru-Soen, Galia“…The current study was performed to determine the impact of routine pneumococcal vaccination on patterns in community-acquired bacteremia (CAB) in the Pediatric population in Israel. …”
Publicado 2017
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1238por Imai, Kentaro, Petigara, Tanaz, Kohn, Melvin A, Nakashima, Kei, Aoshima, Masahiro, Shito, Akihito, Kanazu, Shinichi“…Our results support extending pneumococcal vaccination to younger adults with an underlying medical condition, especially those aged 50–64 years.…”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1239por Bradshaw, Jessica L., Caballero, Armando R., Bierdeman, Michael A., Adams, Kristen V., Pipkins, Haley R., Tang, Aihua, O’Callaghan, Richard J., McDaniel, Larry S.“…IMPORTANCE S. pneumoniae remains the leading cause of bacterial pneumonia despite widespread use of pneumococcal vaccines, forcing the necessity for appropriate treatment to control pneumococcal infections. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
1240por Pavliakova, Danka, Giardina, Peter C., Moghazeh, Soraya, Sebastian, Shite, Koster, Maya, Pavliak, Viliam, McKeen, Andrew, French, Roger, Jansen, Kathrin U., Pride, Michael“…IMPORTANCE The pneumococcal enzyme-linked immunosorbent assay (ELISA) measures IgG antibodies in human serum, and it is an important assay that supports licensure of pneumococcal vaccines. The immune correlate of protection, 0.35 µg/ml of IgG antibodies, was determined by the ELISA method. …”
Publicado 2018
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto